The influence of Lamivudine on the inflammatory and fibrotic serum indexes in patients with chronic hepatitis B
LU Ping-xuan
Abstract
LU Ping-xuan
Abstract
Objective: To investigate the reduction of inflammation and fibrosis in pationts with chronic hepatitis B by Lamivudine. Methods:348 cases were divided into two groups randomly (178 cases in study group treated with 100mg per day, 170 cases in control group). Alanine aminotransferase, total bilirubin ,albumin, globulin, hyaluronic acid, collagen type Ⅳ,procollagen type Ⅲ were detected.Results: These indexes in two groups were improved significantly after the treatment (P0.001), but the study group was more superior to the control group (P0.001).Conclusion:Lamivudine is helpful to reduce the inflammation and fibrosis in chronic hepatitis B.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate the reduction of inflammation and fibrosis in pationts with chronic hepatitis B by Lamivudine. Methods:348 cases were divided into two groups randomly (178 cases in study group treated with 100mg per day, 170 cases in control group). Alanine aminotransferase, total bilirubin ,albumin, globulin, hyaluronic acid, collagen type Ⅳ,procollagen type Ⅲ were detected.Results: These indexes in two groups were improved significantly after the treatment (P0.001), but the study group was more superior to the control group (P0.001).Conclusion:Lamivudine is helpful to reduce the inflammation and fibrosis in chronic hepatitis B.
Key concepts: Lamivudine, Medicine, Chronic hepatitis, Gastroenterology, Fibrosis, Hyaluronic acid, Internal medicine, Albumin